AccuShares(R) Investment Management, LLC Announces Regular

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AccuShares(R) Investment Management, LLC Announces Regular Distribution for the AccuShares Spot CBOE(R) VIX(R) Up Shares and Down Shares and, If Applicable, Net Income Distribution for the AccuShares Spot CBOE VIX Up Shares and Down Shares

STAMFORD, CT --(Marketwired - December 15, 2015) - AccuShares Investment Management, LLC ("AccuShares"), as sponsor of the AccuShares Trust I (formerly known as Accushares Commodities Trust I) (the "Trust"), today announced the Regular Distribution payment for the Spot CBOE VIX Up Shares ( NASDAQ : VXUP ) and Spot CBOE VIX Down Shares ( NASDAQ : VXDN ) , and, if applicable, the Net Income Distribution payment for the AccuShares Spot CBOE VIX Up Shares and Down Shares, as such distributions are described in the current prospectus of the AccuShares Spot CBOE VIX Fund (the "Fund").

The relevant distribution information is provided in the tables below:

Distribution Dates :

                     
NASDAQ Ticker   Name   Ex Date   Record Date   Distribution Payment Date   Regular Distribution Measurement Schedule
VXUP   AccuShares Spot CBOE VIX Up Shares   December 16, 2015   December 18, 2015   December 22, 2015   Monthly
VXDN   AccuShares Spot CBOE VIX Down Shares   December 16, 2015   December 18, 2015   December 22, 2015   Monthly
                     

Distribution Amount Information :

                         
NASDAQ Ticker   Name   Closing Index Value as of December 15, 2015   Post-Distribution Share Index Factor*   Post-Distribution Class Value per Share*   Net Income Distribution Amount   Regular Distribution Amount
VXUP   AccuShares Spot CBOE VIX Up Shares   20.95   0.85918854   $18.00   $0.000000   $4.460163
VXDN   AccuShares Spot CBOE VIX Down Shares   20.95   -0.85918854   $18.00   $0.000000   $0.000000
                         

* As defined in the Fund's prospectus.

More information about the Fund can be found at the Trust's website at www.accushares.com

Investor Reassessment:

Investors wishing to maximize exposure to the index tracked by the Fund, the CBOE Volatility Index, in either direction or investors wishing to compound gains over one or more distribution dates must invest any cash distributed, and sell any shares distributed and invest the sale proceeds thereof, in the class of shares aligned with their investment objectives.

The Fund has been designed to be utilized by investors who are prepared to reassess their holding of the Fund's shares at least as frequently as each distribution date. Investors in the Fund who wish to maintain a maximum exposure, a targeted absolute exposure, or a targeted relative exposure to the Underlying Index over multiple distribution dates should reassess their positions following all cash and share distributions, and all Fund resets relating to the Share Index Factors. The Fund will not compound investor gains or otherwise rebalance investor positions to maximize investor exposure. The Fund is designed to make Regular Distributions of cash and in some cases shares to facilitate regular distribution of investor gains and to promote a deliberate and regular reassessment by investors of their investment in the Fund.

Investors who hold shares over one or more consecutive distribution dates without reassessment of their Fund share portfolio may experience decreased exposure to the Underlying Index as well as a reduced opportunity for gain and loss.

About AccuShares:

Founded in 2011, AccuShares ( www.accusharesinvmgmt.com ) is an innovative financial services firm sponsoring exchange traded products ("ETPs") that provide access to indices in key alternative asset classes, including volatility. AccuShares ETPs offer investors the ability to trade both shares that are positively linked with the ETP's index ("Up Shares") and shares that are negatively linked with such index ("Down Shares"), enabling them to potentially take advantage of opportunity in any market. AccuShares' patent-pending technology and "direct-to-index" quantitative design seeks to reduce overall expenses while also attempting to both simplify tax reporting and provide investors with a predictable cost of ownership and transparency in returns.

Disclosures:

Neither the Trust nor the Fund is an investment company within the meaning of the Investment Company Act of 1940 and neither is subject to regulation thereunder. Although AccuShares is registered as a commodity pool operator with the Commodity Futures Trading Commission ("CFTC"), the Trust and the Fund are not subject to regulation under the Commodities Exchange Act or by the CFTC. Consequently Fund shareholders are not afforded the regulatory protections provided to investors in registered investment companies or commodity pools.

Investing in the Funds involves substantial risk and high volatility, including possible loss of principal. Shares of the fund are intended for sophisticated, professional and institutional investors. The Fund is not intended to be used as a long-term passive investment vehicle and should be used by investors who understand the risks of the volatility market. Investors expecting the Underlying Index to decline should purchase the Fund's Down Shares, and investors expecting the Underlying Index to increase should purchase the Fund's Up Shares, to align their respective Fund investments with their respective expectations. Please read the Fund's prospectus carefully before investing. The Fund's prospectus can be obtained by clicking the link below.

http://www.accushares.com/resources/vix-fund-prospectus

The Trust is a Delaware statutory trust organized by AccuShares into separate fund series. The Fund's shares represent fractional undivided interests in and ownership of the Fund only and not any other series of the Trust or the Trust as a whole. The Fund offers its shares on a continuous basis and is listed on the NASDAQ.

Disclaimers:

The Fund is not sponsored, endorsed, sold or promoted by S&P Dow Jones Indices LLC (the "Index Provider"), Dow Jones Trademark Holdings LLC ("Dow Jones"), Standard & Poor's Financial Services LLC ("S&P"), their respective affiliates or their third party licensors (including The Chicago Board Options Exchange Incorporated ("CBOE")) and none of such parties make any representation or warranty, express or implied, regarding the advisability of investing in securities generally or in the Fund particularly, or the ability of the Underlying Index or any related indices or sub-indices to track the appropriate market performance, or as to the results to be obtained by the Trust, the Fund, the Fund's shareholders or any other person or entity from use of the Underlying Index or any data included therein. None of such parties have any liability for any errors, omissions, or interruptions in the Underlying Index or such data, and the Index Provider and CBOE do not guarantee the accuracy or the completeness of the Underlying Index or such data. Neither the Index Provider nor CBOE make any express or implied warranties, and expressly disclaim all warranties of merchantability or fitness for a particular purpose or use with respect to the Underlying Index or such data. Without limiting any of the foregoing, the Index Provider, Dow Jones, S&P, CBOE, their affiliates and third party licensors expressly disclaim any and all liability for any special, punitive, indirect, or consequential damages (including lost profits), even if notified of the possibility of such damages.

The only relationship of the Index Provider, CBOE, their affiliates or their third party licensors to AccuShares, the trustee of the Trust (the "Trustee"), the Trust or the Fund is the licensing of certain trademarks, trade names and service marks and of the Underlying Index, which is constructed, calculated and published by CBOE, and has been licensed by the Index Provider, without regard to AccuShares, the Trustee, the Trust or the Fund. Neither AccuShares, the Trustee, the Trust nor the Fund have any contractual relationship or other arrangement with CBOE with respect to the use of the Underlying Index and related intellectual property. Instead, the rights of AccuShares, the Trust and the Fund to utilize the Underlying Index and related intellectual property is derivative of the rights of the Index Provider under its agreement with CBOE. CBOE has no obligation to take the needs of AccuShares, the Trustee, the Trust, the Fund or the Fund's shareholders into consideration in determining, composing or calculating the Underlying Index.

Neither the Index Provider, CBOE, nor any of their respective affiliates or third party licensors is responsible for or has participated in the determination of the timing, price or quality of the shares issued by the Fund or in the determination or calculation of the equation by which the shares are to be converted into cash. Neither the Index Provider, CBOE, nor any of their respective affiliates or third party licensors shall have any obligation or liability, including, without limitation, to Fund investors, in connection with the administration, marketing or trading of the Fund.

The Underlying Index is a product of CBOE, which is licensed by the Index Provider or its affiliates to AccuShares in connection with the operation of the Fund. Standard & Poor's ® and S&P ® are registered trademarks of S&P; Dow Jones ® is a registered trademark of Dow Jones; CBOE ® , Chicago Board Options Exchange ® , CBOE Volatility Index ® and VIX ® are registered trademarks of CBOE; and these trademarks have been licensed for use by the Index Provider and sublicensed for certain purposes by AccuShares. AccuShares ™ is a trademark of AccuShares Holdings LLC.

Foreside Fund Services, LLC Marketing Agent

AccuShares investor Service Center 1-855-286-7866 info@accushares.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 7

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 46

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 8

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Costa Rican Firms Chase Growth at SIAL Paris 2026

Updated Category News Views 4

Chasing Growth in Paris: Costa Rica's Bold Move When it comes to playing the global field, Costa Rica isn't just sitting back; they're on the move. Picture this: PROCOMER, along with 18 standout companies, landed smack dab in the grand hustle and bustle of SIAL Paris 2026. This isn't some leisurely stroll—it's a calculated sprint toward expanding their reach across...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 3

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 50

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 3

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Tenant Improvement: Key to Adapting Lease Spaces

Updated Category News Views 0

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 35

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 46

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Against BigBear.ai Holdings: Know Your Rights

Updated Category News Views 246

Class Action Lawsuit Overview Recently, Levi & Korsinsky, LLP has initiated a class action securities lawsuit against BigBear.ai Holdings, Inc. This lawsuit invites affected investors to join in a collective pursuit to recover losses attributed to significant discrepancies in financial reporting and disclosures. BigBear.ai, listed on the NYSE under the ticker BBAI, is at...

Continue Reading
Future of AI in eCommerce Defined at the Ecom AI Summit

Updated Category News Views 392

Defining the Future of AI in eCommerce On June 25, 2025, EcomFounders will host the inaugural Ecom AI Summit, a significant event that brings together the brightest minds in the direct-to-consumer (DTC) sector, including brand owners, marketers, and tech innovators. This summit focuses on the intersection of AI and eCommerce, showcasing how AI is revolutionizing all...

Continue Reading
Growing Concerns: Class Action Lawsuit for Synopsys Investors

Updated Category News Views 106

Introduction to the Lawsuit Against Synopsys, Inc. Levi & Korsinsky, LLP has recently reached out to investors regarding a class action lawsuit concerning Synopsys, Inc. (NASDAQ: SNPS). This lawsuit aims to address concerns among shareholders who may have faced financial losses linked to the company. Understanding the Class Action The principal goal of this lawsuit is to...

Continue Reading
Bango Partners with DISH and Sling for Enhanced Bundling Services

Updated Category News Views 240

Introduction to Bango's Innovative Solutions Bango, a leader in subscription bundling based in Cambridge, United Kingdom, has joined forces with DISH TV, a major player in the telecommunications industry, alongside its streaming service, Sling TV. This partnership is set to revolutionize how subscription services are delivered, thanks to the Digital Vending Machine®...

Continue Reading
Agillic Secures SKI Vendor Status for Public Sector Solutions

Updated Category News Views 133

Agillic Approved as SKI Vendor for the Public Sector In a significant advancement for marketing automation in the public sector, Agillic A/S has received approval as a SKI vendor under the framework agreement ‘02.06 standard software’. This recognition allows various organizations including state entities, regions, and municipalities in Denmark to integrate...

Continue Reading